Power List 2025 coverage.

Who is the best eye doctor in Zurich? In Switzerland? In the world? While such questions are subjective, peer recognition provides meaningful insight. The Ophthalmologist’s biennial Power List 2025 highlights the individuals who are currently shaping the future of eye care.

Among them is Prof. Farhad Hafezi, MD, PhD, FARVO, recognized for his pioneering work in corneal cross-linking (CXL) and refractive surgery. In a recent interview, Prof. Hafezi discusses the evolving landscape of ophthalmology, emphasizing the role of artificial intelligence (AI) and the importance of adaptability in medical careers.

Embracing AI in Ophthalmology

Prof. Hafezi notes that AI and machine learning are transforming ophthalmic diagnostics and treatment planning. He highlights the potential of AI-driven systems to enhance patient care and optimize clinical workflows.

“AI is not just about analyzing retinal scans—it is also about automating patient education, therapy, and follow-ups,” says Prof. Hafezi.

He envisions AI-driven interfaces assisting surgeons, technicians, and patients in decision-making processes, ultimately improving outcomes and efficiency in ophthalmology.

Navigating Career Transitions

Reflecting on his unconventional career path, Prof. Hafezi shares valuable advice for aspiring ophthalmologists. He emphasizes the importance of resilience, risk-taking, and embracing change.

“Do not fear changing fields if necessary. Scientific progress often requires stepping outside of traditional career paths and embracing completely new directions,” he advises.

Prof. Hafezi’s journey from retinal research to corneal innovations exemplifies the benefits of interdisciplinary exploration in advancing medical science.

Recognizing Emerging Talent

In the same feature, Prof. Hafezi acknowledges Dr. Emilio Torres-Netto, MD, PhD, FWCRS as a rising star in ophthalmology. Dr. Torres-Netto’s contributions to corneal biomechanics and cross-linking innovations are reshaping approaches to ectatic diseases.

His work on accelerated and customized CXL protocols, such as ELZA-PACE and ELZA-sub400, has provided critical insights into biomechanical stability and patient outcomes, earning him international recognition.

Read the article here.